Traws Pharma (TRAW) Non-Current Assets (2012 - 2026)
Traws Pharma (TRAW) recorded Non-Current Assets of $2.45 million in Q2 2026, up 871.0% from $252,000 a year earlier but down 1.8% from the prior quarter.
Analysis
Traws Pharma (TRAW) Non-Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Traws Pharma reported Non-Current Assets of $2.64 million.
- Annual Non-Current Assets has a five-year compound annual growth rate of 67.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $11,000 in FY2024 (-52.2%), $23,000 in FY2023 (-8.0%), $25,000 in FY2022 (-47.9%) and $48,000 in FY2021 (-76.2%).
- Quarterly Non-Current Assets has ranged from $11,000 in Q4 2024 to $2.82 million in Q3 2025 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in two of the last four quarters, with growth averaging 439.1%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 989.5% in Q1 2025, against a decline of 77.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.49 million (Q1 2026), $2.64 million (Q4 2025) and $2.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Traws Pharma | 3.89 Mn | -14.50 Mn | - | 2.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.45 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 207,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 54,000.00 |
API Access
Traws Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRAW&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TRAW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TRAW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();